Opiant Pharmaceuticals, Inc. (OPNT): Price and Financial Metrics


Opiant Pharmaceuticals, Inc. (OPNT)

Today's Latest Price: $13.51 USD

0.04 (0.30%)

Updated Dec 6 6:55pm

Add OPNT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

OPNT Stock Summary

  • The ratio of debt to operating expenses for Opiant Pharmaceuticals Inc is higher than it is for about merely 0.39% of US stocks.
  • As for revenue growth, note that OPNT's revenue has grown 52.61% over the past 12 months; that beats the revenue growth of 89.88% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for OPNT comes in at -26.43% -- higher than that of only 12.55% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Opiant Pharmaceuticals Inc are NCR, BLFS, RTIX, LUNA, and HCHC.
  • OPNT's SEC filings can be seen here. And to visit Opiant Pharmaceuticals Inc's official web site, go to www.opiant.com.
OPNT Daily Price Range
OPNT 52-Week Price Range

OPNT Stock Price Chart More Charts


OPNT Price/Volume Stats

Current price $13.51
Prev. close $13.47
Day low $13.30
Day high $13.95
50-day MA $14.68
200-day MA $13.59
52-week high $18.23
52-week low $9.98
Volume 12,700
Avg. volume 20,593
Dividend yield N/A
Market Cap 55.32M

Opiant Pharmaceuticals, Inc. (OPNT) Company Bio


Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops opioid antagonist treatments for addictions and related disorders. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa, an eating disorder; and heroin vaccine. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is based in Santa Monica, California. Opiant Pharmaceuticals, Inc. operates as a subsidiary of Pelikin Group.





OPNT Latest News Stream


Event/Time News Detail
Loading, please wait...

OPNT Latest Social Stream


Loading social stream, please wait...

View Full OPNT Social Stream

OPNT Price Returns

1-mo -14.49%
3-mo 0.07%
6-mo 5.96%
1-year -15.19%
3-year 94.95%
5-year N/A
YTD -6.51%
2018 -37.09%
2017 309.45%
2016 -43.05%
2015 N/A
2014 0.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5266 seconds.